NTRK2 and central nervous system cancer: Investigations have substantiated that BDNF serves as a potent activator of signaling cascades such as BDNF/TrkB/PI3K/Akt and TrkB/ATF4, effectively counteracting the inhibitory and apoptotic impacts of BDNF inhibitors on C6 glioma cells [162, 163].